Novan Therapeutics Obtains $50,000,000 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c8879da-b9ad-4dd7-bff9-a224ee0d26b6 - Date
3/31/2015 - Company Name
Novan Therapeutics - Mailing Address
4222 Emperor Boulevard Durham, NC 27703 USA - Company Description
Novan uses a licensed nitric oxide technology, developed at the lab of Schoenfisch, to give medical devices an antimicrobial coating, helping to fight bacteria. - Website
http://www.novantherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$50,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The funds secured will support Novan’s efforts to create impactful, first-in-class, nitric oxide-based healthcare solutions in a number of large market indications. - M&A Terms
- Venture Investor
- Venture Investor
